The hardware and bandwidth for this mirror is donated by dogado GmbH, the Webhosting and Full Service-Cloud Provider. Check out our Wordpress Tutorial.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]dogado.de.
Write beautiful yet customizable letters in R Markdown and directly obtain the finished PDF. Smooth generation of PDFs is realized by 'rmarkdown', the 'pandoc-letter' template and the 'KOMA-Script' letter class. 'KOMA-Script' provides enhanced replacements for the standard 'LaTeX' classes with emphasis on typography and versatility. 'KOMA-Script' is particularly useful for international writers as it handles various paper formats well, provides layouts for many common window envelope types (e.g. German, US, French, Japanese) and lets you define your own layouts. The package comes with a default letter layout based on 'DIN 5008B'.
Version: | 0.5.0 |
Depends: | R (≥ 3.0) |
Imports: | rmarkdown (≥ 0.6) |
Suggests: | knitr (≥ 1.8) |
Published: | 2023-02-27 |
DOI: | 10.32614/CRAN.package.komaletter |
Author: | Robert Nuske [aut, cre], Dirk Eddelbuettel [aut], Aaron Wolen [aut] |
Maintainer: | Robert Nuske <robert.nuske at mailbox.org> |
BugReports: | https://github.com/rnuske/komaletter/issues |
License: | GPL-3 |
URL: | https://rnuske.github.io/komaletter/, https://github.com/rnuske/komaletter |
NeedsCompilation: | no |
Materials: | README NEWS |
CRAN checks: | komaletter results |
Package source: | komaletter_0.5.0.tar.gz |
Windows binaries: | r-devel: komaletter_0.5.0.zip, r-release: komaletter_0.5.0.zip, r-oldrel: komaletter_0.5.0.zip |
macOS binaries: | r-release (arm64): komaletter_0.5.0.tgz, r-oldrel (arm64): komaletter_0.5.0.tgz, r-release (x86_64): komaletter_0.5.0.tgz, r-oldrel (x86_64): komaletter_0.5.0.tgz |
Old sources: | komaletter archive |
Please use the canonical form https://CRAN.R-project.org/package=komaletter to link to this page.
These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.
Health stats visible at Monitor.